Salt Lake City, UT1 Active Studies

Familial Hypercholesterolemia Clinical Trials in Salt Lake City, UT

Find 1 actively recruiting familial hypercholesterolemia clinical trials in Salt Lake City, UT. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
195
Enrolling

Recruiting Familial Hypercholesterolemia Studies in Salt Lake City

About Familial Hypercholesterolemia Clinical Trials in Salt Lake City

Familial hypercholesterolemia is a genetic condition causing very high LDL cholesterol levels from birth, dramatically increasing the risk of early heart disease. It affects about 1 in 250 people. Treatment includes high-intensity statins, PCSK9 inhibitors, and lifestyle modifications.

There are currently 1 familial hypercholesterolemia clinical trials recruiting participants in Salt Lake City, UT. These studies are seeking a combined 195 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Familial Hypercholesterolemia Clinical Trials in Salt Lake City — FAQ

Are there familial hypercholesterolemia clinical trials in Salt Lake City?

Yes, there are 1 familial hypercholesterolemia clinical trials currently recruiting in Salt Lake City, UT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Salt Lake City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you about next steps.

Are clinical trials in Salt Lake City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Salt Lake City studies also compensate for your time and travel.

What familial hypercholesterolemia treatments are being tested?

The 1 active trials in Salt Lake City are testing new therapies including novel drugs, biologics, and treatment approaches for familial hypercholesterolemia.

Data updated October 16, 2026 from ClinicalTrials.gov